Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

By sjmartinez • August 15, 2024

Rastogi A, Collins A, Kelepouris E, Kotzker W, Middleton JP, Rajpal M, Roy-Chaudhury P, Chertow GM. Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists. J Prim Care Community Health. 2024 Jan-Dec;15:21501319241259905. doi: 10.1177/21501319241259905. PMID: 39143759.

Tags: Chronic kidney disease, consensus, KDIGO, Nephrology, Publications, SGLT2 inhibitor, treatment algorithm

Association of Intravenous Versus Oral Iron Therapy With Clinical Outcomes in Patients With Advanced CKD

Adeboye AM, Shrestha P, Sumida K, Thomas F, Rhee CM, Kalantar-Zadeh K, Kovesdy CP. Association of Intravenous Versus Oral Iron Therapy With Clinical Outcomes in[...]

A Scoping Review of Pharmacist-Based Interprofessional Interventions for Management of Cardiovascular-Kidney-Metabolic Conditions

St Peter WL, Neumiller JJ, Alicic R, Chow SL, Dowell H, Duru OK, Gee P, Mathew RO, Nicholas SB, Rangaswami J, Roberts GV, Vaduganathan M,[...]

Using a generative co-design framework to adapt an exercise intervention as part of a multimodal intervention for patients’ receiving haemodialysis with or at risk of renal cachexia

Blair C, Slee A, McKeaveney C, Maxwell AP, Awan F, Brown M, Carson M, Comer S, Davenport A, Fogarty D, Fouque D, Gooding O, McKinley[...]